• Trinity Delta Futura Medical MED3000 receives CE Mark as a Class II(b) device

  • Trinity Delta Futura Medical FY21 is set to be a year of execution

  • Trinity Delta Futura Medical EU Notified Body recommends MED3000 approval

    Futura Medical EU Notified Body recommends MED3000 approval

  • Trinity Delta Futura Medical Commercialisation deal for China and SE Asia

    Commercialisation deal for China and SE Asia

  • Trinity Delta Futura Medical Lighthouse

    MED3000 FDA details the scope of confirmatory study


  • Trinity Delta Futura Medical MED3000 on course for OTC approval in Europe and US

    MED3000 on course for OTC approval in Europe and US


  • Trinity Delta FDA green lights MED3000 for OTC approval

    FDA green lights MED3000 for OTC approval


  • Trinity Delta Futura Medical Outlook

    Nearing the critical point in Erectile Dysfunction


  • Trinity Delta details more on FM57 Results

    MED3000: more detail on FM57 results


  • Trinity Delta details FY19 results and MED3000 update

    Encouraging FY19 results and MED3000 update


  • Trinity Delta details of the MED3000 European regulatory pathway

    MED3000 European regulatory pathway is clearer


  • Trinity Delta Initiates Coverage

    Initiation of Coverage